Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA2 | P00918 | 3/20 | 0.61 |
| ▸ | GABRA1 | P14867 | 3/20 | 0.53 |
| ▸ | GABRB2 | P47870 | 3/20 | 0.53 |
| ▸ | ATM | Q13315 | 1/20 | 0.47 |
| ▸ | ALOX12 | P18054 | 1/20 | 0.44 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.43 |
| ▸ | TSHR | P16473 | 1/20 | 0.43 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.43 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.41 |
| ▸ | HSPA5 | P11021 | 2/20 | 0.40 |
| ▸ | CYP2C9 | P11712 | 2/20 | 0.39 |
| ▸ | CYP2C19 | P33261 | 2/20 | 0.39 |
| ▸ | HIF1A | Q16665 | 2/20 | 0.39 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.39 |
| ▸ | PNMT | P11086 | 2/20 | 0.38 |
| ▸ | CA1 | P00915 | 1/20 | 0.35 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.35 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.35 |
| ▸ | POLB | P06746 | 1/20 | 0.34 |
| ▸ | TYR | P14679 | 1/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL57139 | 0.83 | GABRA1 (0.67) | CA2GABRA1GABRB2ATMALOX12 | |
| SCHEMBL2935552 | 0.83 | CA2 (0.67) | CA2GABRA1GABRB2ATMALOX12 | |
| Propane SCHEMBL28225674 | 0.82 | GABRA1 (0.64) | CA2GABRA1GABRB2ATMALOX12 | |
| SCHEMBL10706992 | 0.82 | CA2 (0.64) | CA2GABRA1GABRB2ATMALOX12 | |
| SCHEMBL30313045 | 0.80 | MAOB (0.45) | CA2GABRA1GABRB2ATMALDH1A1 | |
| SCHEMBL27555820 | 0.80 | CA2 (0.61) | CA2GABRA1GABRB2ATMALOX12 | |
| SCHEMBL1274723 | 0.80 | CA2 (0.61) | CA2GABRA1GABRB2ATMALOX12 | |
| SCHEMBL9994746 | 0.80 | CA2 (0.61) | CA2GABRA1GABRB2ATMALOX12 | |
| SCHEMBL125128 | 0.79 | PNMT (0.44) | CA2GABRA1GABRB2ALDH1A1TSHR | |
| SCHEMBL15512896 | 0.78 | CA2 (0.59) | CA2GABRA1GABRB2ATMALOX12 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 33 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2912076-B1 | NOVEL CATALYST COMPOSITIONS AND METHOD OF MAKING AND USING THE SAME FOR THE POLYMERIZSATION OF OLEFIN. HIGH DENSITY POLYETHYLENE | CHEVRON PHILLIPS CHEMICAL CO LP (US) | 2024-05-15 | — | — | EP | disclosed |
| CN-105085729-B | A kind of catalytic component and catalyst for olefinic polymerization | 中国石油化工股份有限公司 | 2018-01-23 | — | — | CN | disclosed |
| CN-105085726-B | A kind of catalytic component and catalyst for olefinic polymerization | 中国石油化工股份有限公司 | 2017-11-07 | — | — | CN | disclosed |
| EP-2912076-A1 | NOVEL CATALYST COMPOSITIONS AND METHOD OF MAKING AND USING THE SAME FOR THE POLYMERIZSATION OF OLEFIN, HIGH DENSITY POLYETHYLENE | Chevron Phillips Chemical Company LP (US) | 2015-09-02 | — | — | EP | disclosed |
| EP-2912016-A1 | NOVEL CATALYST COMPOSITIONS AND METHODS OF MAKING AND USING SAME | Chevron Phillips Chemical Company LP (US) | 2015-09-02 | — | — | EP | disclosed |
| US-8937139-B2 | Catalyst compositions and methods of making and using same | CHEVRON PHILLIPS CHEMICAL COMPANY LP (US) | 2015-01-20 | — | — | US | disclosed |
| US-8937139-B2 | Catalyst compositions and methods of making and using same | CHEVRON PHILLIPS CHEMICAL COMPANY LP (US) | 2015-01-20 | — | — | US | disclosed |
| US-8895679-B2 | Catalyst compositions and methods of making and using same | CHEVRON PHILLIPS CHEMICAL COMPANY LP (US) | 2014-11-25 | — | — | US | disclosed |
| US-8895679-B2 | Catalyst compositions and methods of making and using same | CHEVRON PHILLIPS CHEMICAL COMPANY LP (US) | 2014-11-25 | — | — | US | disclosed |
| CN-103772556-A | Novel catalyst composition and methods of making and using same | CHEVRON PHILLIPS CHEMICAL CO | 2014-05-07 | — | — | CN | disclosed |
| US-20100286170-A1 | (3-HYDROXY-4-AMINO-BUTAN-2-YL) -3- (2-THIAZOL-2-YL-PYRROLIDINE-1-CARBONYL) BENZAMIDE DERIVATIVES AND RELATED COMPOUNDS AS BETA-SECRETASE INHIBITORS FOR TREATING | COMENTIS, INC | 2010-11-11 | — | — | US | disclosed |
| US-20100286170-A1 | (3-HYDROXY-4-AMINO-BUTAN-2-YL) -3- (2-THIAZOL-2-YL-PYRROLIDINE-1-CARBONYL) BENZAMIDE DERIVATIVES AND RELATED COMPOUNDS AS BETA-SECRETASE INHIBITORS FOR TREATING | COMENTIS, INC | 2010-11-11 | — | — | US | disclosed |
| CN-101868457-A | (3-hydroxy-4-amino-but-2-yl) -3- (2-thiazol-2-yl-pyrrolidine-1-carbonyl) benzamide derivatives and related compounds as beta-secretase inhibitors for use in therapy | COMENTIS INC | 2010-10-20 | — | — | CN | disclosed |
| CN-101821238-A | Suppress the active isophthaloyl sulfonamide derivatives of beta-secretase (BETA-SECRETASE) | COMENTIS INC | 2010-09-01 | — | — | CN | disclosed |
| EP-2205596-A1 | (3-HYDROXY-4-AMINO-BUTAN-2-YL) -3- (2-THIAZOL-2-YL-PYRROLIDINE-1-CARBONYL) BENZAMIDE DERIVATIVES AND RELATED COMPOUNDS AS BETA-SECRETASE INHIBITORS FOR TREATING | COMENTIS, INC. (US) | 2010-07-14 | — | — | EP | disclosed |
| EP-2178837-A2 | ISOPHTHALAMIDE DERIVATIVES INHIBITING BETA-SECRETASE ACTIVITY | COMENTIS, INC. (US) | 2010-04-28 | — | — | EP | disclosed |
| WO-2009042694-A1 | (3-HYDROXY-4-AMINO-BUTAN-2-YL) -3- (2-THIAZOL-2-YL-PYRROLIDINE-1-CARBONYL) BENZAMIDE DERIVATIVES AND RELATED COMPOUNDS AS BETA-SECRETASE INHIBITORS FOR TREATING | COMENTIS, INC. (US) | 2009-04-02 | — | — | WO | disclosed |
| WO-2009042694-A1 | (3-HYDROXY-4-AMINO-BUTAN-2-YL) -3- (2-THIAZOL-2-YL-PYRROLIDINE-1-CARBONYL) BENZAMIDE DERIVATIVES AND RELATED COMPOUNDS AS BETA-SECRETASE INHIBITORS FOR TREATING | COMENTIS, INC. (US) | 2009-04-02 | — | — | WO | disclosed |
| WO-2009015369-A2 | COMPOUNDS WHICH INHIBIT BETA-SECRETASE ACTIVITY AND METHODS OF USE THEREOF | COMENTIS, INC. (US) | 2009-01-29 | — | — | WO | disclosed |
| WO-2009015369-A2 | COMPOUNDS WHICH INHIBIT BETA-SECRETASE ACTIVITY AND METHODS OF USE THEREOF | COMENTIS, INC. (US) | 2009-01-29 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100286170-A1 | (3-HYDROXY-4-AMINO-BUTAN-2-YL) -3- (2-THIAZOL-2-YL-PYRROLIDINE-1-CARBONYL) BENZAMIDE DERIVATIVES AND RELATED COMPOUNDS AS BETA-SECRETASE INHIBITORS FOR TREATING | BACE1, BACE2, PSEN1 | CA2 2566/4885GABRA1 1384/4885GABRB2 229/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.